These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4156786)

  • 41. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
    Moller Nielsen I
    Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
    [No Abstract]   [Full Text] [Related]  

  • 42. Catecholamines.
    Axelrod J; Weinshilboum R
    N Engl J Med; 1972 Aug; 287(5):237-42. PubMed ID: 4402575
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of ethanol on catecholamine levels and related enzyme activities in different brain regions of rats.
    Yamanaka Y; Egashira T
    Jpn J Pharmacol; 1982 Aug; 32(4):599-606. PubMed ID: 6127425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of apomorphine on behavioural activity and brain catecholamine synthesis in normal and L-triiodothyronine-treated rats.
    Rastogi RB; Singhal RL; Lapierre YD
    J Neural Transm; 1981; 50(2-4):139-48. PubMed ID: 7241114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development of catecholaminergic neurons of the central nervous system.
    Coyle JT
    Neurosci Res (N Y); 1973; 5(0):35-52. PubMed ID: 4152068
    [No Abstract]   [Full Text] [Related]  

  • 46. Tyrosine hydroxylase and dopamine-beta-hydroxylase: distribution in discrete areas of the rat limbic system.
    Saavedra JM; Zivin J
    Brain Res; 1976 Apr; 105(3):517-24. PubMed ID: 4197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system.
    Andén NE; Stock G
    J Pharm Pharmacol; 1973 Apr; 25(4):346-8. PubMed ID: 4146695
    [No Abstract]   [Full Text] [Related]  

  • 48. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
    Strömbom U
    Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
    [No Abstract]   [Full Text] [Related]  

  • 49. Selective lesions of central catecholamine pathways: application in functional studies.
    Ungerstedt U
    Neurosci Res (N Y); 1973; 5(0):73-96. PubMed ID: 4600813
    [No Abstract]   [Full Text] [Related]  

  • 50. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 51. Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 Sep; 26(9):742-3. PubMed ID: 4155757
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
    Lassen JB
    Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728
    [No Abstract]   [Full Text] [Related]  

  • 53. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional catecholamine content in the rat brain: sex differences and correlation with motor activity.
    Gordon JH; Shellenberger K
    Neuropharmacology; 1974 Feb; 13(2):129-37. PubMed ID: 4822599
    [No Abstract]   [Full Text] [Related]  

  • 55. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 56. The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
    Kelly PH; Miller RJ
    Br J Pharmacol; 1975 May; 54(1):115-21. PubMed ID: 1139072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic differences in mechanisms involving neuroregulators.
    Barchas JD; Ciaranello RD; Dominic JA; Deguchi T; Orenberg EK; Renson J; Kessler S
    J Psychiatr Res; 1974; 11():347-60. PubMed ID: 4156789
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
    Lycke E; Roos BE
    J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 60. Pentazocine analgesia and regional rat brain catecholamines.
    Paalzow G; Paalzow L; Stalby B
    Eur J Pharmacol; 1974 Jun; 27(1):78-88. PubMed ID: 4152989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.